From: 13/07/2017 to: 18/07/2017 ESMO-ESO Course on Medical Oncology for Medical Students, Valencia, Spain                                        From: 15/07/2017 to: 15/07/2017 Breast Cancer in Young Women: Joint DFCI-ESO Symposium, Boston, US                                        From: 28/08/2017 to: 08/09/2017 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Antwerp, Belgium                                        From: 06/10/2017 to: 07/10/2017 Eastern Europe and Balkan Region Refresher Course on Breast Cancer, Krakow, Poland                                        From: 18/10/2017 to: 20/10/2017 4th Masterclass in Clinical Oncology, Tbilisi, Georgia                                        From: 18/10/2017 to: 18/10/2017 ESO Breast Cancer Observatory, Tehran, Iran                                        From: 27/10/2017 to: 28/10/2017 9th Clinical Oncology Update - Onkologia 2017, Krakow, Poland                                        From: 02/11/2017 to: 04/11/2017 ESO-ESMO Advanced Breast Cancer Fourth International Consensus Conference (ABC4), Lisbon, Portugal                                        From: 02/12/2017 to: 04/12/2017 ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers, Milan, Italy                                        From: 15/12/2017 to: 18/12/2017 6th Arab and Southern European Countries Masterclass in Clinical Oncology, Limassol, Cyprus                                        From: 24/03/2018 to: 29/03/2018 17th ESO-ESMO Masterclass in Clinical Oncology, Nauen OT Groß Behnitz (Berlin area), Germany                                        From: 18/04/2018 to: 22/04/2018 4th ESO-ESMO Latin-American Masterclass in Clinical Oncology, Mexico City, Mexico                                        From: 6/10/2018 to: 8/10/2018 4th ESO-ESMO Breast Cancer in Young Women International Conference, Lugano, Switzerland


Information for the handling of personal data by the European School of Oncology

Under the Legislative Decree 196/2003 which refers to personal data protection, please be informed herewith that:

Personal data which you have supplied to us will be used electronically and otherwise, for internal and external use, for information purposes exclusively or when drawing up documents to register/participate in training courses run by our School and when sending out publicity material on current and future activities of the School. Data will be processed both confidentially and securely in compliance with the legislative norm.

Should consent not be provided, we might not be able to carry out your requests. The School will not publicise your personal data but will use it solely for the activities of the European School of Oncology and your specific requests both in Italy and abroad.

Your rights in relation to the personal data we use, are outlined in Article 7 DLGS 196/2003.

The data controller is the European School of Oncology Via Turati 29, Milan, Italy. You can contact the person in charge of personal data processing at the following address: Milan (Italy), Via Turati 29, should you wish to assert your rights.

Data protection policy of Ulm University

According to the §11 of the LDSG of Baden-Württemberg, Germany, regarding the code for the protection of personal data, we would like to inform you that the personal data supplied by you and in our possession will be used both in terms of electronic use and without, for internal use and by supplying it to external structures, exclusively based on the demand for information or contract development, in particular for the purposes inherent in subscribing/taking part in training activities held at our Ulm University and in sending informative material relating to current or future activities of the Certificate of Competence in Lymphoma Programme.

The handling of data will be carried out so as to guarantee that current legislative norm is enforced. In the case of you not consenting to the handling of personal data it will be impossible to carry out your requests. The Ulm University will not publicize personal data, however, communicating data or of part of it, both on German territory and abroad, is always and only in relation to the activities of the CC Programme in Lymphoma and to your specific requests. Your rights in relation to the data we handle are specified in §11 of the LDSG of Baden-Württemberg, Germany. The holder of data is the Ulm University, 89069 Ulm, Germany. You can contact the person in charge of the treatment of personal data: Abt. III-2 Recht, Struktur und Verwaltungsorganisation, Helmholtzstraße 16 E16b, 89081 Ulm, Germany, to validate your rights regarding the treatment of personal data.

Professional confidentiality agreement

Participants will be asked to sign the following declaration:

I was informed that I am bound to the medical confidentiality, according to § 203 Strafgesetzbuch (criminal code). As a student of the Certificate of Competence in Lymphoma programme I am allowed to attend seminars, conferences and practical workshops, where individual-related patients’ data might be presented.
According to § 6 Landesdatenschutzgesetz (Federal Data Protection Act), I was informed that it is not permitted  to collect and work with individual-related patients’ data during the Programme and after the Programme is concluded. In detail, participants are not authorised to the:

•    Collection, record, and notice of personal data
•    Transmission of data to third parties inside or outside of the hospital
•    Removal of data

Infringements of the above mentioned restrictions will be regarded as a regulatory or criminal offense and be punished by exclusion of the study programme.

Lecturers will be asked to sign the following declaration:

I was informed that I am bound to the medical confidentiality, according to § 203 Strafgesetzbuch (criminal code). As a lecturer of the Certificate of Competence in Lymphoma programme I am allowed to present lectures and materials at seminars, conferences or workshops which will be uploaded to the programme platform, where individual-related patients’ data are presented.
Nevertheless, it is essential to ensure that patients are not, and cannot be identified in any of the materials presented.